DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ advanced 3.29% to $208.45 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.79% to 7,736.52 and the Dow Jones Industrial Average rising 1.71% to 54,085.88.
The stock's rise snapped a three-day losing streak.
Biogen Inc. closed 5.13% below its 52-week high of $219.72, which the company achieved on June 29th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.20% to $254.93, Pfizer Inc. $(PFE)$ rose 1.52% to $25.41, and AbbVie Inc. $(ABBV)$ fell 0.53% to $243.80.
Trading volume (1.2 M) remained 74,825 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 4, 2026.
Comments